I reported previously on Israel’s CytoReason which uses an Artificial Intelligent learning model to discover treatments related to the human immune system. CytoReason has just partnered with Pfizer – its fifth alliance with a major company.
http://nocamels.com/2019/01/drug-discovery-cytoreason-pfizer/
https://docs.wixstatic.com/ugd/216dd2_5d94d4baffe5460d80e3fcbe79c5c1ea.pdf